Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan vs Irinotecan + Oxaliplatin in metastatic colorectal cancer
NCT00012389Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 7
01
Overview
A Phase 3 trial of oxaliplatin in colorectal cancer (metastatic) (mCRC), sponsored by Sanofi. Started Dec 2000; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00012389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00012389.